Table 2 Standardised incidence ratios (SIRs) and their 95% CIs for oesophageal cancer by histology among non‐operated patients with duodenal ulcer, by follow‐up duration, sex, presence of complications and calendar year of index hospitalisation*.
Adenocarcinoma | Squamous cell carcinoma | |||
---|---|---|---|---|
Number of cases | SIR (95% CI) | Number of cases | SIR (95% CI) | |
Overall | 27 | 1.7 (1.1–2.5) | 44 | 1.3 (0.96–1.8) |
Follow‐up duration, years | ||||
2–10 | 17 | 1.9 (1.1–3.1) | 33 | 1.6 (1.1–2.2) |
11+ | 10 | 1.5 (0.7–2.8) | 11 | 0.9 (0.5–1.6) |
p for trend | 0.15 | 0.01 | ||
Sex | ||||
Men | 23 | 1.7 (1.1–2.5) | 34 | 1.3 (0.9–1.8) |
Women | 4 | 2.1 (0.6–5.5) | 10 | 1.5 (0.7–2.7) |
Complication† | ||||
Yes | 12 | 1.2 (0.6–2.1) | 30 | 1.4 (0.95–2.0) |
No | 15 | 2.6 (1.5–4.3) | 14 | 1.2 (0.6–2.0) |
Calendar year of index hospitalisation | ||||
1965–79 | 10 | 2.1 (1.0–3.8) | 18 | 1.3 (0.8–2.1) |
1980–2003 | 17 | 1.6 (0.9–2.5) | 26 | 1.3 (0.9–2.0) |
Age at entry | ||||
<50 | 6 | 2.4 (0.9–5.1) | 9 | 2.0 (0.9–3.8) |
50–69 | 15 | 1.9 (1.1–3.1) | 25 | 1.4 (0.9–2.1) |
70– | 6 | 1.2 (0.4–2.5) | 10 | 0.9 (0.4–1.6) |
p for trend | 0.09 | <0.001 | ||
Calendar year of follow‐up | ||||
1965–94 | 13 | 2.3 (1.2–4.0) | 25 | 1.2 (0.8–1.8) |
1995–2003 | 14 | 1.4 (0.8–2.3) | 19 | 1.5 (0.9–2.3) |
*First year of follow‐up was excluded.
†Including bleeding and perforation.